Effects of glucagon-like peptide 1 on glycemia control and its metabolic consequence after severe thermal injury - Studies in an animal model

Surgery

Volumn 149, Issue 5, 2011, Pages 635-644

  Shen, Chuan An ^a,b   Fagan, Shawn ^a   Fischman, Alan J ^a   Carter, Edward E ^a   Chai, Jia Ke ^b   Lu, Xiao Ming ^a   Yu, Yong Ming ^a,c   Tompkins, Ronald G ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; PROTEIN BCL 2; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY SURFACE; BURN; CONTROLLED STUDY; DISEASE SEVERITY; ENERGY EXPENDITURE; GLUCOSE TOLERANCE TEST; GLYCEMIC CONTROL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN METABOLISM; RAT; THERMAL INJURY;

ANIMALS; BLOOD GLUCOSE; BURNS; CASPASE 3; ENERGY METABOLISM; GLUCAGON-LIKE PEPTIDE 1; HYPERGLYCEMIA; INCRETINS; INSULIN; INSULIN RESISTANCE; ISLETS OF LANGERHANS; MALE; MODELS, ANIMAL; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, INBRED STRAINS;

EID: 79954633530     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2010.11.017     Document Type: Article

References (50)

1. E. Hirshberg, G. Larsen, and H. Van Duker Alterations in glucose homeostasis in the pediatric intensive care unit: Hyperglycemia and glucose variability are associated with increased mortality and morbidity Pediatr Crit Care Med 9 2008 361 366
2. W.L. Wahl, M. Taddonio, P.M. Maggio, S. Arbabi, and M.R. Hemmila Mean glucose values predict trauma patient mortality J Trauma 65 2008 42 47
3. M. Kaneki, M. Sakai, N. Shimizu, and K. Chang Is normalized mean blood glucose level good enough for the intensive care unit?-glycemic variability as a new independent predictor of mortality Crit Care Med 36 2008 3104 3106
4. L.A. Simons, J. Simons, Y. Friedlander, and J. McCallum Usefulness of fasting plasma glucose to predict mortality or coronary heart disease in persons > or =60 years of age without diabetes mellitus or in those with undiagnosed diabetes mellitus (from The Dubbo Study) Am J Cardiol 102 2008 831 834
5. G. van den Berghe, P. Wouters, F. Weekers, C. Verwaest, F. Bruyninckx, and M. Schetz Intensive insulin therapy in the critically ill patients N Engl J Med 345 2001 1359 1367
6. G. Van den Berghe, A. Wilmer, G. Hermans, W. Meersseman, P.J. Wouters, and I. Milants Intensive insulin therapy in the medical ICU N Engl J Med 354 2006 449 461 (Pubitemid 43200296)
7. C.C. Reed, R.M. Stewart, M. Sherman, J.G. Myers, M.G. Corneille, and N. Larson Intensive insulin protocol improves glucose control and is associated with a reduction in intensive care unit mortality J Am Coll Surg 204 2007 1048 1054 (Pubitemid 46661216)
8. S.E. Inzucchi, and M.D. Siegel Glucose control in the ICU-how tight is too tight? N Engl J Med 360 2009 1346 1349
9. K.A. Malmberg, S. Efendic, and L.E. Rydén Feasibility of insulin-glucose infusion in diabetic patients with acute myocardial infarction. A report from the multicenter trial: DIGAMI Diabetes Care 17 1994 1007 1014 (Pubitemid 24268612)
10. L.A. Dossett, H. Cao, N.T. Mowery, M.J. Dortch, J.M. Morris Jr., and A.K. May Blood glucose variability is associated with mortality in the surgical intensive care unit Am Surg 74 2008 679 685
11. J.J. Meier, and M.A. Nauck Glucagon-like peptide 1(GLP-1) in biology and pathology Diabetes Metab Res Rev 21 2005 91 117 (Pubitemid 40467658)
12. L.L. Baggio, and D.J. Drucker Biology of incretins: GLP-1 and GIP Gastroenterology 132 2007 2131 2157 (Pubitemid 46711096)
13. M.A. Nauck Unraveling the science of incretin biology Am J Med 122 2009 S3 S10
14. E.E. Frezza, M.S. Wachtel, and M. Chiriva-Internati The multiple faces of glucagon-like peptide-1-obesity, appetite, and stress: what is next? A review Dig Dis Sci 52 2007 643 649
15. M. Zander, S. Madsbad, J.L. Madsen, and J.J. Holst Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study Lancet 359 2002 824 830 (Pubitemid 34233752)
16. G.S. Meneilly, N. Greig, H. Tildesley, J.F. Habener, J.M. Egan, and D. Elahi Effects of 3 months of continuous subcutaneous administration of glucagon-like peptide 1 in elderly patients with type 2 diabetes Diabetes Care 26 2003 2835 2841 (Pubitemid 37205555)
17. K.B. Hansen, F.K. Knop, J.J. Holst, and T. Vilsbøll Treatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists Int J Clin Pract 63 2009 1154 1160
18. L.A. Nikolaidis, S. Mankad, G.G. Sokos, G. Miske, A. Shah, and D. Elahi Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion Circulation 109 2004 962 965 (Pubitemid 38282847)
19. R.D. Reigle, and N.F. Bukva A method of restraining rats for intravenous injection using a flexible plastic bag Lab Anim Sci 34 1984 497 498
20. M. Brissova, M. Shiota, W.E. Nicholson, M. Gannon, S.M. Knobel, and D.W. Piston Reduction in pancreatic transcription Factor PDX-1 impairs glucose-stimulated insulin secretion J Biol Chem 277 2002 11225 11232 (Pubitemid 34952885)
21. Y. Stefan, P. Meda, M. Neufeld, and L. Orci Stimulation of insulin secretion reveals heterogeneity of pancreatic B Cells in vivo J Clin Invest 80 1987 175 183 (Pubitemid 17097531)
22. R.R. Wolfe, R.D. Goodenough, J.F. Burke, and M.H. Wolfe Response of protein and urea kinetics in burn patients to different levels of protein intake Ann Surg 197 1983 163 171 (Pubitemid 13184441)
23. N. Liadis, K. Murakami, M. Eweida, A.R. Elford, L. Sheu, and H.Y. Gaisano Caspase-3-dependent beta-cell apoptosis in the initiation of autoimmune diabetes mellitus Mol Cell Biol 25 2005 3620 3629 (Pubitemid 40559568)
24. K. Yamada, F. Ichikawa, S. Ishiyama-Shigemoto, X. Yuan, and K. Nonaka Essential role of caspase-3 in apoptosis of mouse beta-cells transfected with human Fas Diabetes 48 1999 478 483 (Pubitemid 29106859)
25. R. Lupi, F. Dotta, L. Marselli, S. Del Guerra, M. Masini, and C. Santangelo Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated Diabetes 51 2002 1437 1442 (Pubitemid 34826609)
26. Y.M. Yu, R.G. Tompkins, C.M. Ryan, and V.R. Young The metabolic basis of the increase of the increase in energy expenditure in severely burned patients JPEN J Parenter Enteral Nutr 23 1999 160 168 (Pubitemid 29218482)
27. T. Otonkoski, and A. Hayek Constitution of a biphasic insulin response to glucose in human fetal pancreatic beta-cells with glucagon-like peptide 1 J Clin Endocrinol Metab 80 1995 3779 3783
28. J. Schirra, and B. Goke The physiological role of GLP-1 in human: incretin, ileal brake or more? Regul Pept 128 2005 109 115 (Pubitemid 40380911)
29. A. Mari, A. Gastaldelli, A. Natali, T. Ostergard, O. Schmitz, and E. Ferrannini Characterization of beta-cell function impairment in first-degree relatives of type 2 diabetic subjects: modeling analysis of 24-h triple-meal tests Am J Physiol Endocrinol Metab 288 2005 E541 E546
30. C. Herrmann, R. Göke, G. Richter, H.C. Fehmann, R. Arnold, and B. Göke Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients Digestion 56 1995 117 126
31. L.J. Magnotti, and E.A. Deitch Burns, bacterial translocation, gut barrier function, and failure J Burn Care Rehabil 26 2005 383 391 (Pubitemid 41433676)
32. F. Yi, J. Sun, G.E. Lim, I.G. Fantus, P.L. Brubaker, and T. Jin Cross talk between the insulin and Wnt signaling pathways: evidence from intestinal endocrine L cells Endocrinology 149 2008 2341 2351 (Pubitemid 351574509)
33. L. Hansen, C.F. Deacon, C. Orskov, and J.J. Holst Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine Endocrinology 140 1999 5356 5363
34. A. Plamboeck, J.J. Holst, R.D. Carr, and C.F. Deacon Neutral endopeptidase 24.11 and dipeptidyl peptidase IV are both mediators of the degradation of glucagon-like peptide 1 in the anaesthetised pig Diabetologia 48 2005 1882 1890 (Pubitemid 41317844)
35. L. Farilla, H. Hui, C. Bertolotto, E. Kang, A. Bulotta, and U. Di Mario Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker Diabetic rats Endocrinology 143 2002 4397 4408 (Pubitemid 35239574)
36. B. Kreymann, G. Williams, M.A. Ghatei, and S.R. Bloom Glucagon-like peptide-1 7-36: a physiological incretin in man Lancet 2 8571 1987 1300 1304 (Pubitemid 17156636)
37. J. Larsen, B. Hylleberg, K. Ng, and P. Damsbo Glucagon-like peptide-1 infusion must be maintained for 24 h/day to obtain acceptable glycemia in type 2 diabetic patients who are poorly controlled on sulphonylurea treatment Diabetes Care 24 2001 1416 1421 (Pubitemid 33716430)
38. K. Fukuzuka, J.J. Rosenberg, G.C. Gaines, C.K. Edwards III, M. Clare-Salzler, and S.L. MacKay Caspase-3-dependent organ apoptosis early after burn injury Ann Surg 229 1999 851 858
39. M.G. Jeschke, J.F. Low, M. Spies, R. Vita, H.K. Hawkins, and D.N. Herndon Cell proliferation, apoptosis, NF-kappaB expression, enzyme, protein, and weight changes in livers of burned rats Am J Physiol Gastrointest Liver Physiol 280 2001 G1314 G1320
40. G. Gravante, D. Delogu, and G. Sconocchia "Systemic apoptotic response" after thermal burns Apoptosis 12 2007 259 270 (Pubitemid 46172421)
41. K. Toyoda, T. Okitsu, S. Yamane, T. Uonaga, X. Liu, and N. Harada GLP-1 receptor signaling protects pancreatic beta cells in intraportal islet transplant by inhibiting apoptosis Biochem Biophys Res Commun 367 2008 793 798
42. I.A. Urusova, L. Farilla, H. Hui, and E. D'Amico Perfetti R.GLP-1 inhibition of pancreatic islet cell apoptosis Trends Endocrinol Metab 15 2004 27 33 (Pubitemid 38198096)
43. A.M. Woolfson, R.V. Heatley, and S.P. Allison Insulin to inhibit protein catabolism after injury N Engl J Med 300 1979 14 17 (Pubitemid 9095977)
44. Y. Sakurai, A. Aarsland, D.N. Herndon, D.L. Chinkes, E. Pierre, and T.T. Nguyen Stimulation of muscle protein synthesis by long-term insulin infusion in severely burned patients Ann Surg 222 1995 283 294
45. J.B. Boord, R.A. Greevy, S.S. Braithwaite, P.C. Arnold, P.M. Selig, and H. Brake Evaluation of hospital glycemic control at US academic medical centers J Hosp Med 4 2009 35 44
46. M.M. Fatourechi, Y.C. Kudva, M.H. Murad, M.B. Elamin, C.C. Tabini, and V.M. Montori Clinical review: Hypoglycemia with intensive insulin therapy: a systematic review and meta-analyses of randomized trials of continuous subcutaneous insulin infusion versus multiple daily injections J Clin Endocrinol Metab 94 2009 729 740
47. M.R. Rickels, R. Mueller, J.F. Markmann, and A. Naji Effect of glucagon-like peptide-1 on beta- and alpha-cell function in isolated islet and whole pancreas transplant recipients J Clin Endocrinol Metab 94 2009 181 189
48. A. Redondo, M.V. Trigo, A. Acitores, I. Valverde, and M.L. Villanueva-Peñacarrillo Cell signalling of the GLP-1 action in rat liver Mol Cell Endocrinol 204 2003 43 50 (Pubitemid 36871551)
49. N. González, A. Acitores, V. Sancho, I. Valverde, and M.L. Villanueva-Peñacarrillo Effect of GLP-1 on glucose transport and its cell signalling in human myocytes Regul Pept 126 2005 203 211 (Pubitemid 40128185)
50. L. Arnés, N. González, P. Tornero-Esteban, V. Sancho, A. Acitores, and I. Valverde Characteristics of GLP-1 and exendins action upon glucose transport and metabolism in type 2 diabetic rat skeletal muscle Int J Mol Med 22 2008 127 132